Tag Archives: Spinal cord injury

Stem Cell Treatment Helps Spinal Cord Injury

Stem Cell Treatment Helps Spinal Cord Injury
Due to the wonders of Adult Stem Cell treatment, yet another spinal cord injury patient has improved his quality of life.  A young man in India who had lost all sensations from a car accident has been helped after receiving his own Adult Stem Cells and having them injected […]

Positive interim data from Spinal cord injury trial

StemCells Inc announced that interim six-month data from the first patient cohort in the Company’s Phase I/II clinical trial of its proprietary HuCNS-SC(R) product candidate (purified human neural stem cells) for chronic spinal cord injury continues to demonstrate a favorable safety profile, and shows considerable gains in sensory function in two of the three patients compared to pre-transplant baselines. The third patient remains stable.

The data was presented by Armin Curt, M.D., principal investigator for the clinical trial, at the 51st Annual Scientific Meeting of the International Spinal Cord Society in London, England. The trial represents the first
Read More…

Spinal Cord Injury

Stem Cell Research Clinical Study- Spinal Cord Injury
A few weeks ago, I covered a story about  a stem cell research published study for spinal cord injury patients in Ecuador.  In that study, Dr. Luis Geffner used 3 different delivery methods of Adult Stem Cells to help 52 spinal cord injury patients and counting.
Michael Flounders- Walking […]

Stem Cell Company Presents Findings Of Adult Stem Cell Safety And Feasibility Study

DaVinci Biosciences LLC, of Costa Mesa, CA, announced today the presentation of their safety and feasibility study demonstrating the administration of autologous bone marrow derived stem cells for the treatment of acute and chronic spinal cord injury at Neuroscience 2009, Society for Neuroscience’s 39th Annual Meeting, to be held at McCormick Convention Center in Chicago, IL. Rafael Gonzalez, Ph.D., Director of Research and Development for DaVinci Biosciences LLC will present the work during the conference on October 20, 2009 and be available to answer questions regarding the study, following his presentation.

“We are excited to share the findings
Read More…

StemCells Inc Announces Closing of $20 MLN Offering

StemCells Inc announced that it has closed its previously announced offering of common stock and short term warrants. The Company sold a total of 11,299,435 units to two well recognized institutional biotechnology investors and received total proceeds, net of offering expenses and placement agent fees, of approximately $18.7 million.

Each unit consists of one share of common stock and a warrant to purchase 0.85 of a share of common stock at a price of $1.77 per unit. The warrants will first be exercisable six months from the date of issuance at an initial exercise price of $2.17 per share. The
Read More…